Literature DB >> 28252658

Prognostic neurodevelopmental testing of preterm infants: do we need to change the paradigm?

H W Kilbride1, G P Aylward2, L W Doyle3, L T Singer4, J Lantos5.   

Abstract

Longitudinal follow-up with assessment of developmental status at about 2 years of age is routine for high-risk newborns. The results of these assessments can be used for many purposes, including helping physicians, parents, and teachers plan educational or developmental interventions. These assessments also provide outcome measures for clinical research studies. Outcome results may also serve as a source of information for clinicians when counseling parents regarding provision of care for extreme preterm infants. Consideration should be given to use of different outcome metrics based on the purpose for testing. Categorization of composite cognitive, motor and neurosensory findings to define levels of impairment should be limited to research. Planning for individual interventions is better guided by descriptive findings. Current tools for assessing neurodevelopmental status at 2 years of age have important limitations. First, outcomes at early ages do not always predict function later in life. They are, at best, an estimate of longer-term outcomes, with important individual variation. For infants without severe neurologic injury, postnatal environmental factors play a predominant role in determining long-term cognitive and academic outcomes. Further investigations should assess quality of life and other considerations that are important for parents when making decisions about neonatal intensive care unit care for their infant.

Entities:  

Mesh:

Year:  2017        PMID: 28252658     DOI: 10.1038/jp.2017.12

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  10 in total

1.  Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical Trials.

Authors:  Lois E H Smith; Ann Hellström; Andreas Stahl; Alistair Fielder; Wiley Chambers; Jane Moseley; Cynthia Toth; David Wallace; Brian A Darlow; Jacob V Aranda; Boubou Hallberg; Jonathan M Davis
Journal:  JAMA Ophthalmol       Date:  2019-03-01       Impact factor: 7.389

2.  Changes in Neurodevelopmental Outcomes From Age 2 to 10 Years for Children Born Extremely Preterm.

Authors:  Genevieve L Taylor; Robert M Joseph; Karl C K Kuban; Laurie M Douglass; Jeff Laux; Bree Andrews; Rebecca C Fry; Wayne A Price; Thomas M O'Shea
Journal:  Pediatrics       Date:  2021-04-06       Impact factor: 7.124

3.  Accuracy of the Bayley-II mental development index at 2 years as a predictor of cognitive impairment at school age among children born extremely preterm.

Authors:  Thomas M O'Shea; Robert M Joseph; Elizabeth N Allred; H Gerry Taylor; Alan Leviton; Tim Heeren; Laurie M Douglass; Jean A Frazier; Hernan Jara; Karl C K Kuban
Journal:  J Perinatol       Date:  2018-05-29       Impact factor: 2.521

4.  Average 2.5-year neurodevelopmental test results in children born very preterm did not rule out cognitive deficits at 6.5 years of age.

Authors:  Ylva F Kaul; Nima Naseh; Katarina Strand Brodd; Birgitta Böhm; Gerd Holmström; Lena Hellström-Westas
Journal:  Acta Paediatr       Date:  2020-10-21       Impact factor: 2.299

5.  The relationship of neurodevelopmental impairment to concurrent early childhood outcomes of extremely preterm infants.

Authors:  Matthew A Rysavy; Tarah T Colaizy; Carla M Bann; Sara B DeMauro; Andrea F Duncan; Jane E Brumbaugh; Myriam Peralta-Carcelen; Heidi M Harmon; Karen J Johnson; Susan R Hintz; Betty R Vohr; Edward F Bell
Journal:  J Perinatol       Date:  2021-03-23       Impact factor: 2.521

6.  Parental perspective on important health outcomes of extremely preterm infants.

Authors:  Magdalena Jaworski; Annie Janvier; Claude Julie Bourque; Thuy-An Mai-Vo; Rebecca Pearce; Anne R Synnes; Thuy Mai Luu
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2021-11-23       Impact factor: 6.643

7.  Association of Severe Retinopathy of Prematurity and Bronchopulmonary Dysplasia with Adverse Neurodevelopmental Outcomes in Preterm Infants without Severe Brain Injury.

Authors:  Seong Phil Bae; Seung Han Shin; Young Mi Yoon; Ee-Kyung Kim; Han-Suk Kim
Journal:  Brain Sci       Date:  2021-05-26

8.  Fifty Years of Research on Prenatal Substances: Lessons Learned for the Opioid Epidemic.

Authors:  Lynn T Singer; Christina Chambers; Claire Coles; Julie Kable
Journal:  Advers Resil Sci       Date:  2020-10-27

9.  The effect of long chain polyunsaturated fatty acid supplementation on intelligence in low birth weight infant during lactation: A meta-analysis.

Authors:  Yuan Song; Ya Liu; Yun Pan; Xiaofeng Yuan; Pengyu Chang; Yuan Tian; Weiwei Cui; Dong Li
Journal:  PLoS One       Date:  2018-04-10       Impact factor: 3.240

Review 10.  Dose-Related Adverse Drug Events in Neonates: Recognition and Assessment.

Authors:  Karel Allegaert; John van den Anker
Journal:  J Clin Pharmacol       Date:  2021-06       Impact factor: 3.126

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.